Gestational Diabetes clinical trials
54 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- RCT Glargine vs NPH for Treatment of DM in Pregnancy
- Mobile App Logging for Diabetes in Pregnancy
- Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
- Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- DETERMINE: Detemir vs NPH
- Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes
- Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- GDM: Insulin with or Without Metformin?
- Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
- Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
- Maternal Probiotic Supplementation for Improved Outcomes in Infants of Diabetic Mothers
- Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes
- Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes
- A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
- Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
- Poi for Mama: a Pilot to Improve Maternal Microbiome and Gestational Diabetes Risk
- Nutrition Optimization and Community Upliftment for Postpartum Recovery
- Glucose Empowerment Through Monitoring and Social Support in Pregnancy
- Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs
- Harvesting Health: Advancing Nutrition and Wellness for Moms and Babies
- Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
- CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
- Early Detection of Gestational Diabetes Mellitus in Pregnancy
- Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial
- iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
- Preventing T2DM After GDM With Immediate Postpartum Screening
- Validating CGM for GDM
- Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
- Pregnancy and Postpartum CGM in GDM
- Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
- Immediate Postpartum Glucose Tolerance Testing
- Cardiometabolic Disease and Substrate Metabolism
- Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
- Growth Hormone Resistance of Beta-cells A
- Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
- The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy
- Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM
- Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes
- Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
- Study of Fetal Health Outcomes: Working With a Missouri E-telehealth Platform (The SHOW-ME Study)
- Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and Satisfaction
- Fueling Labor: Protein Supplementation for Intrapartum Glucose Control
- Lifestyle Interventions to Improve Glycemic Parameters and Reduce Gestational Diabetes in High-risk Pregnant Individuals
- Produce Rx in High Risk Pregnant Mothers at Harris Health
- Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness
- Pilot Study of Continuous Glucose Monitoring for Postpartum Glucose Screening
- Study to Understand Risk Information to Support and Empower
- Physical Acvitiy in Pregnancy
- Continuation of the nuMoM2b Heart Health Study
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Gestational Diabetes” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.